Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
We have produced adriamycin (ADM)-resistant variants of the human lung cancer cell lines NCI-H69 (small cell), MOR (adenocarcinoma) and COR-L23 (large cell) but have failed to produce resistant variants of two other small cell lines. In each case, the derivation protocol took 7-9 months and included...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1986
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001423/ |